Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/1999
03/18/1999CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999CA2303248A1 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
03/18/1999CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use
03/18/1999CA2301979A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999CA2301969A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
03/18/1999CA2300387A1 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
03/17/1999EP0902036A1 Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds
03/17/1999EP0902025A2 Benzothiophenes for treatment of estrogen related conditions
03/17/1999EP0901482A1 Benzofuran carboxamides and their therapeutic use
03/17/1999EP0901466A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
03/17/1999EP0901459A1 Calcilytic compounds
03/17/1999EP0901378A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
03/17/1999EP0901373A1 Alpha v Beta 3 ANTAGONISTS
03/17/1999EP0733065B1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
03/17/1999EP0637245B1 Preparations of low molecular weight hyaluronic acid for stimulating bone formation
03/16/1999US5883294 Selective thyroid hormone analogs
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883114 Indolocarbazole imides and the use thereof
03/16/1999US5882656 Useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and
03/16/1999CA2165012C Estrogen agonists
03/11/1999WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/11/1999WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999WO1999011640A1 Epoxysuccinamide derivatives
03/11/1999WO1999011637A1 Protease inhibitors
03/11/1999WO1999011628A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999WO1999011626A1 Integrin receptor antagonists
03/11/1999WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
03/11/1999WO1999011608A1 Malonic acid based matrix metalloproteinase inhibitors
03/11/1999WO1999011605A1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
03/11/1999WO1999011293A1 50 human secreted proteins
03/11/1999WO1999011292A2 Compositions and methods for treating arthritis utilizing gene therapy
03/11/1999WO1999011287A1 Ligands that modulate differentiation of mesenchymal stem cells
03/11/1999WO1999011264A1 Il-8 receptor antagonists
03/11/1999WO1999011253A1 Il-8 receptor antagonists
03/11/1999WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
03/11/1999CA2304117A1 Integrin receptor antagonists
03/11/1999CA2302450A1 Il-8 receptor antagonists
03/11/1999CA2302364A1 Il-8 receptor antagonists
03/11/1999CA2302361A1 Protease inhibitors
03/11/1999CA2302037A1 Malonic acid based matrix metalloproteinase inhibitors
03/11/1999CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999CA2294110A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900844A2 Membrane protein of Staphylococcus aureus
03/10/1999EP0900569A2 Therapeutic agent for herniated intervertebral disc
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999EP0900225A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
03/10/1999EP0900211A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
03/10/1999EP0900201A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
03/10/1999EP0900199A1 Azetidinone derivatives for the treatment of atherosclerosis
03/10/1999EP0900198A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/10/1999EP0900083A1 Novel substituted imidazole compounds
03/10/1999EP0785769B1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof
03/10/1999CN1210534A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/10/1999CN1210532A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/10/1999CN1210530A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/10/1999CN1210529A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/10/1999CN1210528A Dihydrobenzofuran compounds useful as anti-inflammatory agents
03/10/1999CN1210527A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/10/1999CN1210517A Hydroxamic acid derivatives for use with treatment of diseases related to connective tissue degradation
03/09/1999US5880160 Antiproliferative, antineoplastic, antiinflammatory and muscle relaxant activities
03/09/1999US5880124 For treatment of hypotension
03/09/1999US5880094 Polypeptides that stimulate bone growth
03/09/1999US5879698 Calcium dietary supplement
03/04/1999WO1999010502A1 Human nucleotide pyrophosphohydrolase
03/04/1999WO1999010371A2 Cyclopeptide derivatives as adhesion inhibitors
03/04/1999WO1999010339A1 2-aminopyridines containing fused ring substituents as nos inhibitors
03/04/1999WO1999010332A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1999010322A1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
03/04/1999WO1999010313A1 N-aroylphenylalanine derivatives
03/04/1999WO1999010312A1 N-alkanoylphenylalanine derivatives
03/04/1999WO1999009991A1 Novel amide derivatives
03/04/1999WO1999009978A1 Method for treatment of non-rheumatoid athritis
03/04/1999CA2301661A1 Human nucleotide pyrophosphohydrolase
03/04/1999CA2301586A1 Method for treatment of non-rheumatoid arthritis
03/04/1999CA2301566A1 N-acylated lipophilic amino acid derivatives
03/04/1999CA2301182A1 Cyclopeptide derivatives
03/04/1999CA2300121A1 N-alkanoylphenylalanine derivatives
03/04/1999CA2294548A1 Pyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
03/04/1999CA2242258A1 Novel compounds
03/04/1999CA2242254A1 Novel tig
03/03/1999EP0899336A2 Streptococcus pneumoniae spoIIIE protein
03/03/1999EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus
03/03/1999EP0899332A2 The G-protein coupled receptor HFIAO41
03/03/1999EP0898562A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation
03/03/1999EP0898478A1 Stimulation of host defence mechanisms against tumors
03/03/1999EP0754190B1 An equilin double bond isomer from the acid isomerization of equilin
03/03/1999CN1209744A Vitronectin receptor antagonists
03/03/1999CA2242313A1 Signal recognition particle polypeptides and polynucleotides
03/02/1999US5877219 Non-steroidal ligands for the estrogen receptor
03/02/1999US5877207 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/02/1999US5877176 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
03/02/1999US5876963 Human nucleotide pyrophosphohydrolase
03/02/1999CA2242315A1 Mecb
1 ... 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 ... 820